SCHEMBL15020718

SCHEMBL15020718

CCC1C[CH]OCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19665529 0.67
SCHEMBL12630 0.66
SCHEMBL147332 0.64
SCHEMBL2184846 0.62
SCHEMBL28629064 0.62
SCHEMBL631210 0.62
SCHEMBL1564430 0.62
SCHEMBL13021 0.62
SCHEMBL1524605 0.60
SCHEMBL5345214 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721026-B1 PHOSPHATE ESTERS OF GYRASE AND TOPOISOMERASE INHIBITORS VERTEX PHARMA (US) 2016-03-02 EP claimed
US-9125922-B2 Phosphate esters of gyrase and topoisomerase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-09-08 US claimed
US-20130157979-A1 PHOSPHATE ESTERS OF GYRASE AND TOPOISOMERASE INHIBITORS SPERO THERAPEUTICS, INC. 2013-06-20 US claimed
EP-2721026-B1 PHOSPHATE ESTERS OF GYRASE AND TOPOISOMERASE INHIBITORS VERTEX PHARMA (US) 2016-03-02 EP disclosed
US-9125922-B2 Phosphate esters of gyrase and topoisomerase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-09-08 US disclosed
US-20130157979-A1 PHOSPHATE ESTERS OF GYRASE AND TOPOISOMERASE INHIBITORS SPERO THERAPEUTICS, INC. 2013-06-20 US disclosed